CMANY
CELG

Capital Management Associates (New York)’s Celgene Corp CELG Stock Holding History

Capital Management Associates (New York)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,700
Closed -$242K – 135
2018
Q3 		$242K Hold
2,700
– – 0.3% 124
2018
Q2 		$214K Hold
2,700
– – 0.27% 131
2018
Q1 		$241K Buy
+2,700
New +$259K 0.37% 113
2016
Q1 		– Sell
-2,500
Closed -$299K – 136
2015
Q4 		$299K Buy
+2,500
New +$289K 0.43% 106

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Management Associates (New York)'s CELG Position: Q4 2018 in Review

Capital Management Associates (New York) sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,700 shares — an estimated $242K sold.

Capital Management Associates (New York) first reported a position in CELG in Q4 2015 and held it in 4 quarters. The position peaked at $299K in Q4 2015. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Capital Management Associates (New York) reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Capital Management Associates (New York) sold 2,700 Celgene Corp shares in Q4 2018, an estimated $242K.
  • Capital Management Associates (New York) first reported a position in Celgene Corp in Q4 2015 and held it in 4 quarters.
  • Capital Management Associates (New York)'s Celgene Corp position peaked at $299K in Q4 2015.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Capital Management Associates (New York)'s 13F filing for Q4 2018, filed 11 Feb 2019.